43 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
designating a lead independent director to take on responsibility for functions in which they all currently participate might detract from rather … consistent with its fiduciary duty to the stockholders. This significant responsibility requires highly skilled individuals with various qualities
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
to enter into collaborations for the manufacture of our product candidates, with our collaborators assuming responsibility for such manufacturing … Financial Officer with the responsibility of managing the cybersecurity risk assessment and mitigation process.
As part of our overall risk management
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
OR REPRESENTATIONS IN CONFLICT WITH OR IN ADDITION TO THE INFORMATION IN THIS AGREEMENT AND BSL SPECIFICALLY DISCLAIMS ANY RESPONSIBILITY FOR ANY SUCH STATEMENTS
8-K
EX-10.3
vvvmwlyviice2ldqkj0
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-10.1
fblcqz6
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
d7jwj
24 Aug 23
Prospectus supplement
2:00pm
DEF 14A
d869jpmsnbas6 2iok4m
21 Nov 22
Definitive proxy
5:28pm
8-K
EX-3.1
ipandqbbqv3lq
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
DRS
h6up4y
29 Sep 22
Draft registration statement
12:00am
424B4
g1791dcalef toj3h
31 Aug 22
Prospectus supplement with pricing info
6:16am
CORRESP
3vyl5tj8
25 Aug 22
Correspondence with SEC
12:00am